Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B. Coutts, Robert Simister, Zarina Assis et al.|The Lancet|2024Cited by 134
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 TrialAmy Yu, Andrew Micielli, Shabnam Vatanpour et al.|Journal of the American Heart Association|2025Cited by 1